Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
48 studies found for:    alzheimer's OR alzheimer's disease | Open Studies | NIH
Show Display Options
Rank Status Study
1 Recruiting Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Meganatural-Az Grapeseed Extract;   Drug: Placebo
2 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
3 Recruiting Sleep, Aging and Risk for Alzheimer's Disease
Conditions: Sleep Disordered Breathing;   Alzheimer's Disease
Intervention: Device: Continuous positive airway pressure (CPAP)
4 Recruiting Alzheimer's Prevention Through Exercise
Condition: Alzheimer's Disease
Interventions: Other: Aerobic Exercise;   Other: Standard of Care
5 Recruiting Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
Condition: Genetic Risk for Alzheimer's Disease
Interventions: Drug: donepezil HCL;   Drug: Placebo
6 Recruiting Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
Condition: Dementia Alzheimer's Type
Interventions: Drug: Sargramostim GZ402664;   Drug: Placebo;   Drug: Florbetapir F18
7 Recruiting Dominantly Inherited Alzheimer Network (DIAN)
Condition: Alzheimer's Disease
Intervention:
8 Recruiting Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Conditions: Mild Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Allopregnanolone injection (intravenous solution);   Drug: Placebo injection (intravenous solution)
9 Recruiting Treatment of Psychosis and Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Psychosis;   Agitation
Interventions: Drug: Lithium;   Drug: Placebo
10 Not yet recruiting The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
Conditions: Alzheimer's Disease;   Dementia
Interventions: Other: Placebo;   Other: Medication Therapy Management (MTM);   Drug: Scopolamine patch
11 Recruiting Alzheimer's Caregiver Coping: Mental and Physical Health
Conditions: Alzheimer Disease;   Alzheimer Dementia;   Alzheimer's Disease;   Dementia
Interventions: Behavioral: Behavioral Activation;   Behavioral: Information and Support
12 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
13 Recruiting Human Brain Antioxidants During Oxidative Stress
Conditions: Oxidative Stress;   Alzheimer's Disease;   Aging
Intervention:
14 Recruiting Arterial Spin Labeling (ASL) MRI for Cognitive Decline
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: FDG-PET;   Other: ASL-MRI;   Procedure: Lumbar Puncture
15 Recruiting Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
Conditions: Alzheimer's Disease;   Cognitive Impairment
Intervention: Other: Mediterranean Diet
16 Recruiting Apathy in Dementia Methylphenidate Trial 2
Conditions: Apathy;   Alzheimer's Disease
Interventions: Drug: Methylphenidate;   Drug: Placebo
17 Recruiting Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Conditions: Alzheimer's Disease;   Obesity;   Diabetes Mellitus
Interventions: Dietary Supplement: Boost A;   Behavioral: Healthy Living Diet
18 Recruiting Imaging of Cognition, Learning, and Memory in Aging
Condition: Alzheimer's Disease
Intervention: Drug: Florbetaben
19 Recruiting Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Conditions: Alzheimer Disease;   Mild Cognitive Impairment;   Delirium, Dementia, Amnestic, Cognitive Disorders
Intervention: Drug: Donepezil
20 Recruiting A Study of Crenezumab Versus Placebo in Preclinical PSEN1 E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease (AD), Including a Placebo-Treated Noncarrier Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.